"Uric Acid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
| Descriptor ID |
D014527
|
| MeSH Number(s) |
D03.132.960.877 D03.633.100.759.758.824.877
|
| Concept/Terms |
Uric Acid- Uric Acid
- Acid, Uric
- 2,6,8-Trihydroxypurine
- Trioxopurine
Sodium Urate Monohydrate- Sodium Urate Monohydrate
- Monohydrate, Sodium Urate
- Urate Monohydrate, Sodium
- Monosodium Urate Monohydrate
- Monohydrate, Monosodium Urate
- Urate Monohydrate, Monosodium
- Sodium Acid Urate Monohydrate
- Sodium Urate
- Urate, Sodium
- Monosodium Urate
- Urate, Monosodium
- Sodium Acid Urate
- Acid Urate, Sodium
- Urate, Sodium Acid
|
Below are MeSH descriptors whose meaning is more general than "Uric Acid".
Below are MeSH descriptors whose meaning is more specific than "Uric Acid".
This graph shows the total number of publications written about "Uric Acid" by people in this website by year, and whether "Uric Acid" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 1 | 1 |
| 2008 | 3 | 0 | 3 |
| 2010 | 1 | 1 | 2 |
| 2011 | 2 | 0 | 2 |
| 2013 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 2 | 1 | 3 |
| 2017 | 37 | 18 | 55 |
| 2018 | 42 | 16 | 58 |
| 2019 | 11 | 5 | 16 |
| 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Uric Acid" by people in Profiles.
-
Distinct Regulation of U-ACE2 and P-ACE2 (Urinary and Plasma Angiotensin-Converting Enzyme 2) in a Japanese General Population. Hypertension. 2021 09; 78(4):1138-1149.
-
Serum uric acid, disease severity and outcomes in COVID-19. Crit Care. 2021 06 14; 25(1):212.
-
Association of serum uric acid levels with COVID-19 severity. BMC Endocr Disord. 2021 May 08; 21(1):97.
-
Serum Uric Acid Concentrations and Risk of Adverse Outcomes in Patients With COVID-19. Front Endocrinol (Lausanne). 2021; 12:633767.
-
Acute and severe ribavirin-associated hyperuricemia and acute kidney injury: An underrecognized adverse effect. Am J Health Syst Pharm. 2021 04 22; 78(9):794-799.
-
Laboratory Predictors of COVID-19 Mortality: A Retrospective Analysis from Tongji Hospital in Wuhan. Mediators Inflamm. 2021; 2021:6687412.
-
The Metabolic Changes and Immune Profiles in Patients With COVID-19. Front Immunol. 2020; 11:2075.
-
Acute Gouty Arthritis During Favipiravir Treatment for Coronavirus Disease 2019. Intern Med. 2020 Sep 15; 59(18):2327-2329.
-
Characteristics of laboratory findings of COVID-19 patients with comorbid diabetes mellitus. Diabetes Res Clin Pract. 2020 Sep; 167:108351.
-
Could urinary ACE2 protein level help identify individuals susceptible to SARS-CoV-2 infection and complication? Sci China Life Sci. 2020 11; 63(11):1766-1767.